The Generalist The Future Of Drug Discovery Is 4 Billion Years Old (Viswa Colluru, Founder & CEO at Enveda)
26 snips
Apr 21, 2026 Viswa Colluru, founder and CEO of Enveda Biosciences who builds AI tools to discover medicines from natural products. He recounts his pharmacy roots and his mother’s illness. He argues pharma wrongly abandoned nature, explains Enveda’s chemistry-first platform, shares how they found dozens of candidates and moved three into trials, and describes scalable, cost-efficient lab strategies.
AI Snips
Chapters
Books
Transcript
Episode notes
Lead With Urgency And Do The Work Yourself
- Adopt a bias toward urgent, hands-on action as a leader; Viswa learned this from Recursion's CEO who would do tasks like move furniture after hours.
- This urgency culture reduces bureaucracy and helps early startups out-execute larger incumbents.
Use Ethnobotany To Narrow Nature's Search Space
- Prioritize plants with convergent use across cultures to increase hit rates; ethnobotanical overlap predicts functional relevance.
- Enveda published that independently used plants for similar symptoms are statistically unlikely to be random.
Eighteen Candidates From Fewer Than 80 Plants
- From under 80 targeted plants Enveda produced about a dozen of its first candidates, demonstrating high yield from guided ethnobotanical selection.
- Viswa calls this 'low hanging fruit' and notes the pipeline shows no sign of running out.
